 This is an investigator-initiated study of safety, efficacy and tolerability of dutasteride given for 18 months, including a 1-year double-blind randomized co-administration with either tolterodine ER or placebo in men suffering from lower urinary tract symptoms LUTS including urgency and frequency, with or without urgency urinary incontinence i.e., overactive bladder OAB symptoms. 